GAGNON SECURITIES LLC

Broker-Dealer

Position in RNTX — Rein Therapeutics, Inc.

CIK 1125725 New York, NY

Position in RNTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$238,232

-$73,144 QoQ

Shares Held

229,070

-4.4% QoQ

Ownership

0.266%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#23

of 59 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GAGNON SECURITIES LLC holds $7,175,658 across 5 Biotechnology names. RNTX ranks #4 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CELC	Celcuity Inc.	53,240	$5,569,968
2	TECH	BIO-TECHNE Corp	12,230	$864,049
3	VCEL	Vericel Corp	7,303	$324,910
4	RNTX	Rein Therapeutics, Inc. This page	229,070	$238,232
5	ATNM	Actinium Pharmaceuticals, Inc.	182,142	$178,499

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$238,232	229,070	-4.4%	Shares	Sole	2026-08-05
2026-03-31	$311,376	239,520	-0.3%	Shares	Sole	2026-04-22
2025-12-31	$278,655	240,220	+5.0%	Shares	Sole	2026-02-13
2025-09-30	$261,852	228,692	+218.8%	Shares	Sole	2025-11-03
2025-06-30	$100,443	71,745	0.0%	Shares	Sole	2025-07-23
2025-03-31	$126,988	71,745	0.0%	Shares	Sole	2025-05-09
2024-12-31	$165,013	71,745	-0.0%	Shares	Sole	2025-01-24
2024-09-30	$254,033	71,761	+89.0%	Shares	Sole	2024-11-12
2024-06-30	$105,196	37,977	+0.1%	Shares	Sole	2024-08-14
2024-03-31	$251,588	37,947	0.0%	Shares	Sole	2024-05-13
2023-12-31	$115,700	37,947	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.